Talk:Pharmaceutical industry

Wiki Education Foundation-supported course assignment
This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 October 2021 and 9 December 2021. Further details are available on the course page. Student editor(s): Tzc0725.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 02:18, 18 January 2022 (UTC)

Wiki Education Foundation-supported course assignment
This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Yennnnhix.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 06:30, 17 January 2022 (UTC)

Research and development section edit: Not a word about Aspirin?
Central to the Spanish Flu epidemic(s) Ing.walter.hartmann (talk) 09:27, 22 June 2019 (UTC)

This link leads to an empty address. Janice Vian, Ph.D. (talk) 16:09, 26 July 2021 (UTC)

Controversies
The „Controversies“ section only talks about the situation in the US given that all numbers, sources,… are from the United States. Some of the information might be misleading for people from other countries with different regulations. I propose to add a disclaimer at the beginning of the section to say that this chapter shows the US side of things and might not represent the situation in other countries Akdns (talk) 07:58, 16 October 2022 (UTC)

Impact of Mergers and Acquisitions
I've added a brief section to the article that relates to this topic with only a single citation. I believe that this is a VERY under-appreciated aspect of the Pharma Industry and should be addressed in more depth and detail. Many (if not most) of the History sections of major pharma are replete with M&A activities, implicitly noting that these are significant events for the involved companies. I'm not a historian, so I'm not sure how to best address this, but I am SURE that this is not a 20th-21st Century phenomenon and it would be useful to see whether the impact in the "digital era" is greater than in the "industrial era", and specifically what that impact was. Thanks for considering this. --User:Ceyockey ( talk to me ) 04:01, 24 December 2022 (UTC) (P.S. I was at one time involved in M&A activities in the pharma that I'm currently employed by ... it is a non-trivial exercise that involves huge amounts of financial and human capital)